Recombinant antigen LipL21 for Leptospira interrogans

Leptospira interrogans

LipL21 is one of the important surface-exposed lipoproteins in leptospires and the most effective cross protective immunogenic antigen. This recombinant antigen is a Novel Surface-Exposed Lipoprotein of Pathogenic Leptospira Species and highly immunogenic, being recognized by immune sera from humans and hamsters infected with Leptospira.

More information about Leptospirosis caused by Leptospira interrogans.

or
Name
LipL21
Description
The second most abundant protein in Leptospira interrogans
Gene
LipL21
Purity
> 95% by observation on SDS-PAGE electrophoresis
Cat number
SKU Source Applications In-house validation Details
RAG0100 P. pastoris WB, DB, IE, DE, CLIA, LF Immunoassay blocker - Example of a certificate of analysis Material Safety Data Sheet
WB: Western Blot | DB: Dot Blot | IE: Indirect ELISA | DE: positive control in Direct ELISA | CLIA: Chemiluminescent immunoassay | LF: Lateral-Flow | CE: Capture ELISA | DAS: Double Antigen Sandwich ELISA | NP: Nanoparticles binding | PO: Plate orientation | COA: Certificate of analysis | SDS: Material Safety Data Sheet
Immunoassay blocker Due to the nonspecific interaction with anti-CCDs present in normal human or animal sera, we strongly recommend using our blocker SOR0001 on the analyzed sera in any immunoassay.
Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk
* under availability, for liquid format
Related proteins
LipL32

Also avaliable for diagnosis of Leptospirosis caused by Leptospira interrogans in animals

For research and comercial use IVD only (*)

(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.

Bact to list of Proteins for human infectious diseases

How to reconsitute lyophizated vials

How to use the inmunoassay blocker for anti-cross-reactive carbohydrate determinants (CCD) antibodies